A business in context

ROIV research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-01 · 0001807359-26-000018

  2. 4 · Ownership change

    Report date 2026-10-01 · 0001140361-26-038692

  3. 4 · Ownership change

    Report date 2026-09-30 · 0001635088-26-000109

  4. 4 · Ownership change

    Report date 2026-09-30 · 0001635088-26-000108

  5. 4 · Ownership change

    Report date 2026-09-30 · 0001140361-26-038475

  6. 4 · Ownership change

    Report date 2026-09-30 · 0001140361-26-038474

  7. 4 · Ownership change

    Report date 2026-09-20 · 0001635088-26-000104

  8. 4 · Ownership change

    Report date 2026-09-20 · 0001140361-26-037363

  9. 8-K · Current report

    Report date 2026-09-16 · 0001635088-26-000095 · Items 5.07,9.01

  10. 8-K · Current report

    Report date 2026-09-08 · 0001140361-26-035859 · Items 7.01,9.01

  11. 8-K · Current report

    Report date 2026-08-28 · 0001140361-26-034854 · Items 8.01,9.01

  12. 8-K · Current report

    Report date 2026-08-27 · 0001140361-26-034735 · Items 7.01,9.01

  13. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001635088-26-000090

  14. 8-K · Current report

    Report date 2026-08-06 · 0001635088-26-000088 · Items 2.02,9.01

  15. DEF 14A · Proxy statement

    Report date 2026-09-16 · 0001140361-26-029955

  16. 10-K · Annual report

    Report date 2026-03-31 · 0001635088-26-000061

  17. 8-K · Current report

    Report date 2026-05-20 · 0001635088-26-000060 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2026-04-02 · 0001140361-26-012885 · Items 2.02,7.01,9.01

  19. 8-K/A · Current report

    Report date 2026-03-03 · 0001140361-26-010656 · Items 1.01,9.01

  20. 8-K · Current report

    Report date 2026-03-03 · 0001140361-26-007548 · Items 1.01,7.01,8.01,9.01

  21. 8-K · Current report

    Report date 2026-03-03 · 0001140361-26-007447 · Items 7.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-12-31 · 0001635088-26-000011

  23. 8-K · Current report

    Report date 2026-02-06 · 0001635088-26-000009 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-12-11 · 0001140361-25-045204 · Items 7.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001635088-25-000016

  26. 8-K · Current report

    Report date 2025-11-10 · 0001140361-25-041269 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-09-17 · 0001140361-25-035190 · Items 7.01,8.01,9.01

  28. 8-K · Current report

    Report date 2025-09-10 · 0001140361-25-034711 · Items 5.07,9.01

  29. 8-K · Current report

    Report date 2025-09-03 · 0001140361-25-033767 · Items 7.01,8.01,9.01

  30. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001140361-25-030001

  31. 8-K · Current report

    Report date 2025-08-11 · 0001140361-25-029998 · Items 2.02,9.01

  32. DEF 14A · Proxy statement

    Report date 2025-09-10 · 0001140361-25-027846

  33. 8-K · Current report

    Report date 2025-06-24 · 0001140361-25-023553 · Items 8.01,9.01

  34. 10-K · Annual report

    Report date 2025-03-31 · 0001140361-25-020715

  35. 8-K · Current report

    Report date 2025-05-29 · 0001140361-25-020713 · Items 2.02,9.01

  36. 8-K · Current report

    Report date 2025-04-21 · 0001140361-25-014642 · Items 7.01,9.01

  37. 8-K · Current report

    Report date 2025-03-16 · 0001140361-25-009696 · Items 5.02,9.01

  38. 8-K · Current report

    Report date 2025-03-19 · 0001140361-25-009362 · Items 7.01,8.01,9.01

  39. 8-K · Current report

    Report date 2025-02-19 · 0001140361-25-005445 · Items 5.02,9.01

  40. 10-Q · Quarterly report

    Report date 2024-12-31 · 0001140361-25-003661

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 18 transaction rows18SGrant / award: 15 transaction rows15AExercise / conversion: 23 transaction rows23MTax / exercise payment: 12 transaction rows12FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

68 matching transaction rows. Showing 51 to 68.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-14
2026-08-18
Sukhatme MayukhM · Exercise / conversion
Acquired
Common Shares243177.03.85
2026-08-14
2026-08-18
Sukhatme MayukhM · Exercise / conversion
Disposed
Common Shares
Derivative security
243177.00.0
2026-07-27
2026-07-29
Venker EricS · Sale
Disposed
Common Shares200000.034.95
2026-07-27
2026-07-29
Venker EricM · Exercise / conversion
Acquired
Common Shares200000.03.85
2026-07-27
2026-07-29
Venker EricM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
200000.00.0
2026-07-17
2026-07-21
MOMTAZEE JAMES CA · Grant / award
Acquired
Common Shares405.00.0
2026-07-17
2026-07-21
Epperly Melissa B,A · Grant / award
Acquired
Common Shares543.00.0
2026-07-17
2026-07-21
Oren IlanA · Grant / award
Acquired
Common Shares775.00.0
2026-06-30
2026-07-02
Gline MatthewF · Tax / exercise payment
Disposed
Common Shares76171.035.39
2026-06-30
2026-07-02
Torti FrankF · Tax / exercise payment
Disposed
Common Shares40310.035.39
2026-06-30
2026-07-02
Sukhatme MayukhF · Tax / exercise payment
Disposed
Common Shares46878.035.39
2026-06-30
2026-07-02
Fitzgerald Meghan
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Shares10000.08.8
2026-06-30
2026-07-02
Fitzgerald Meghan
10b5-1 checkbox reported
S · Sale
Disposed
Common Shares10000.034.9
2026-06-30
2026-07-02
Fitzgerald Meghan
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
10000.00.0
2026-06-29
2026-07-01
Epperly Melissa B,
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Shares17750.04.46
2026-06-29
2026-07-01
Epperly Melissa B,
10b5-1 checkbox reported
S · Sale
Disposed
Common Shares2748.034.71
2026-06-29
2026-07-01
Epperly Melissa B,
10b5-1 checkbox reported
S · Sale
Disposed
Common Shares15002.034.32
2026-06-29
2026-07-01
Epperly Melissa B,
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
17750.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001635088Roivant Sciences Ltd.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2025-03-31$29.05M$31.00M
    2024-03-31$32.71M$35.89M
    2023-03-31$31.53M$35.80M
    2022-03-31$55.29M$67.45M
    2021-03-31$23.80M$30.83M

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗